Cardinal Health, Inc (NYSE: CAH) kicked off on Tuesday, down -1.42% from the previous trading day, before settling in for the closing price of $120.03. Over the past 52 weeks, CAH has traded in a range of $93.17-$126.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 9.33% over the last five years. While this was happening, its average annual earnings per share was recorded 3.44%. With a float of $241.33 million, this company’s outstanding shares have now reached $244.00 million.
The firm has a total of 48900 workers. Let’s measure their productivity. In terms of profitability, gross margin is 3.31%, operating margin of 0.97%, and the pretax margin is 0.79%.
Cardinal Health, Inc (CAH) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Distribution Industry. The insider ownership of Cardinal Health, Inc is 0.28%, while institutional ownership is 88.93%. The most recent insider transaction that took place on Nov 14 ’24, was worth 432,919. In this transaction Chief Accounting Officer of this company sold 3,504 shares at a rate of $123.55, taking the stock ownership to the 8,752 shares. Before that another transaction happened on Aug 21 ’24, when Company’s Chief Legal/Compliance Officer sold 16,573 for $109.39, making the entire transaction worth $1,812,920. This insider now owns 75,971 shares in total.
Cardinal Health, Inc (CAH) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 3.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.00% during the next five years compared to -5.30% drop over the previous five years of trading.
Cardinal Health, Inc (NYSE: CAH) Trading Performance Indicators
Take a look at Cardinal Health, Inc’s (CAH) current performance indicators. Last quarter, stock had a quick ratio of 0.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.13. Likewise, its price to free cash flow for the trailing twelve months is 26.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.15, a number that is poised to hit 1.76 in the next quarter and is forecasted to reach 8.63 in one year’s time.
Technical Analysis of Cardinal Health, Inc (CAH)
Analysing the last 5-days average volume posted by the [Cardinal Health, Inc, CAH], we can find that recorded value of 2.9 million was better than the volume posted last year of 2.11 million. As of the previous 9 days, the stock’s Stochastic %D was 42.22%. Additionally, its Average True Range was 2.99.
During the past 100 days, Cardinal Health, Inc’s (CAH) raw stochastic average was set at 76.32%, which indicates a significant increase from 58.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.50% in the past 14 days, which was higher than the 22.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $113.36, while its 200-day Moving Average is $106.38. Now, the first resistance to watch is $119.79. This is followed by the second major resistance level at $121.25. The third major resistance level sits at $122.05. If the price goes on to break the first support level at $117.53, it is likely to go to the next support level at $116.73. Should the price break the second support level, the third support level stands at $115.27.
Cardinal Health, Inc (NYSE: CAH) Key Stats
The company with the Market Capitalisation of 28.64 billion has total of 242,010K Shares Outstanding. Its annual sales at the moment are 226,827 M in contrast with the sum of 852,000 K annual income. Company’s last quarter sales were recorded 52,277 M and last quarter income was 416,000 K.